Alirocumab for hyperlipidemia: physiology of PCSK9 inhibition, pharmacodynamics and Phase I and II clinical trial results of a PCSK9 monoclonal antibody
- 期刊名称Future Cardiology
- 作者Roth, Eli M; Diller, Philip
- 卷第10卷
- 期第2期
- 印刷ISSN1479-6678
- 电子ISSN1744-8298
- 文件大小4067.32KB
- 发表时间2014-03
- DOI10.2217/fca.13.107
- 页码183-199
Total synthesis of (.+-.)-isocomenePirrung, Michael C. · Journal of the American Chemical Society · 1979
Decomposition of Malonic AnhydridesPerrin, Charles L.; Flach, Agnes; Manalo, Marlon N. · Journal of the American Chemical Society · 2012
Emissive RNA AlphabetShin, Dongwon; Sinkeldam, Renatus W.; Tor, Yitzhak · Journal of the American Chemical Society · 2011
Total Synthesis of (−)-IsoschizogamineMiura, Yusuke; Hayashi, Noriyuki; Yokoshima, Satoshi; Fukuyama, Tohru · Journal of the American Chemical Society · 2012
A Concise Synthesis of (+)-ArtemisininZhu, Chunyin; Cook, Silas P. · Journal of the American Chemical Society · 2012
Janus Colloidal MatchsticksChaudhary, Kundan; Chen, Qian; Juárez, Jaime J.; Granick, Steve; Lewis, Jennifer A. · Journal of the American Chemical Society · 2012
Trifluoromethylation of α-HaloketonesNovák, Petr; Lishchynskyi, Anton; Grushin, Vladimir V. · Journal of the American Chemical Society · 2012
Spotlights on Recent <i>JACS</i> PublicationsHayashi, Shinji; Okamoto, Takayuki · Journal of the American Chemical Society · 2012